Addiction July 2023 PMID 36967706

Phenobarbital for alcohol withdrawal in the context of the opioid epidemic: a neglected caveat.

Dale Terasaki, Brian Kulick, Susan Calcaterra, Lance Ray

Mentions

8
Peak: 5 in Apr 2023
across 2 sources since Apr 2023

Extended reach

18,681
potential audience

Total likes

124

Video views

2,216

Mentions per month

Apr 2023 – Jul 2023

Where it's discussed

  • X / Twitter6 posts
  • YouTube2 videos

AI synopsis

What people are saying

The posts convey a moderate level of interest by emphasizing the importance of considerations when reintroducing phenobarbital in alcohol withdrawal treatment, with phrases like 'important considerations' and references to editorials. The tone is professional and cautious, indicating an engagement rooted in clinical relevance but without strong advocacy or opposition, reflecting their balanced impact.

AgreementNeither agree nor disagree

The posts acknowledge the importance of the article but do not explicitly support or oppose its conclusions, indicating neutrality.

InterestModerate interest

Posts show moderate interest by referencing the return of phenobarbital use and the importance of considerations, which suggests curiosity about the topic.

EngagementModerate engagement

Discussions include sharing of editorial insights and calls to consider important points, reflecting some depth of engagement.

ImpactNeutral impact

While the posts highlight considerations relevant to clinical practice, they do not seem to directly influence policy or widespread practice changes, leading to a neutral impact score.

Abstract in brief

  • Phenobarbital, when used for alcohol withdrawal, can interfere with opioid recovery treatments like buprenorphine and methadone, potentially causing delays in withdrawal and increasing relapse risk.
  • As phenobarbital becomes more common in alcohol withdrawal protocols, it’s important to implement safety measures to prevent harm, especially in patients also struggling with opioid use disorder.
  • Generally, it’s advisable to avoid prescribing phenobarbital to patients who have both alcohol withdrawal and opioid use disorder to reduce the risk of negative interactions and improve treatment outcomes.]

Top posts

Most liked on X and Bluesky
Lance Ray
@LRayRx · X

As we return to more phenobarb use for AWS there are some important considerations we should keep in mind. Here is our editorial in @AddictionJrnl #EMRx #TwitteRx https://t.co/XlnkCLVowB

Apr 22, 2023 · 37 likes · 4 shares · 1,083 followers View post →
Addiction Journal
@AddictionJrnl · X

RT @LRayRx: As we return to more phenobarb use for AWS there are some important considerations we should keep in mind. Here is our editoria…

Apr 25, 2023 · 4 shares · 15,010 followers View post →
Ari Filip
@AriFilipMD · X

RT @LRayRx: As we return to more phenobarb use for AWS there are some important considerations we should keep in mind. Here is our editoria…

Apr 23, 2023 · 4 shares · 150 followers View post →
DT
@djterasaki · X

For the most in-the-weeds EDITORIAL you will ever read, check out my paper (no paywall): https://t.co/63bexXi1pW

Jun 24, 2023 · 118 followers View post →
Sean Lynch
@SeanLynchMD · X

RT @LRayRx: As we return to more phenobarb use for AWS there are some important considerations we should keep in mind. Here is our editoria…

Apr 26, 2023 · 4 shares · 51 followers View post →
Yarely
@YarelyRx · X

RT @LRayRx: As we return to more phenobarb use for AWS there are some important considerations we should keep in mind. Here is our editoria…

Apr 23, 2023 · 4 shares · 14 followers View post →

All mentions

DT
@djterasaki · X

For the most in-the-weeds EDITORIAL you will ever read, check out my paper (no paywall): https://t.co/63bexXi1pW

Jun 24, 2023 · 118 followers View post →
Sean Lynch
@SeanLynchMD · X

RT @LRayRx: As we return to more phenobarb use for AWS there are some important considerations we should keep in mind. Here is our editoria…

Apr 26, 2023 · 4 shares · 51 followers View post →
Addiction Journal
@AddictionJrnl · X

RT @LRayRx: As we return to more phenobarb use for AWS there are some important considerations we should keep in mind. Here is our editoria…

Apr 25, 2023 · 4 shares · 15,010 followers View post →
Ari Filip
@AriFilipMD · X

RT @LRayRx: As we return to more phenobarb use for AWS there are some important considerations we should keep in mind. Here is our editoria…

Apr 23, 2023 · 4 shares · 150 followers View post →
Yarely
@YarelyRx · X

RT @LRayRx: As we return to more phenobarb use for AWS there are some important considerations we should keep in mind. Here is our editoria…

Apr 23, 2023 · 4 shares · 14 followers View post →
Lance Ray
@LRayRx · X

As we return to more phenobarb use for AWS there are some important considerations we should keep in mind. Here is our editorial in @AddictionJrnl #EMRx #TwitteRx https://t.co/XlnkCLVowB

Apr 22, 2023 · 37 likes · 4 shares · 1,083 followers View post →